In This Section

Home / About / Awards & Recognition / Clinical Research Award

Clinical Research Award

The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community.

Nomination and Selection Process

Nominations are open now. To be considered by the Award Selection Committee for nomination for this award, please fill out the nomination form and submit it to Betsy Spruill, Member and Volunteer Engagement Manager, ACCC, by June 15, 2020.

The Award Selection Committee will review the applicants and nominees and select the candidate to recommend to the Board of Trustees for approval. The winner is then notified and recognized during the 37th National Oncology Conference in the fall.

Eligibility Criteria

  • Nominee must be able to accept the award during the National Oncology Conference.
  • Nominee MUST be a nationally recognized leader in cancer patient care.
  • Nominee will have made a national contribution in screening, prevention, and treatment; survivorship; patient advocacy; and/or laboratory science.

Award Winner Recognition

The Annual Achievement Award recipient is recognized during the ACCC National Oncology Conference in the fall. The winner receives the following:

  • $1,000 cash award plus a plaque
  • Travel expenses (TBD)
  • Conference registration fee waived
  • Featured in press release to local and national outlets
  • Acknowledgment through the ACCC website, electronic communications, and social media platforms
View Past Winners
Questions? Please email Betsy Spruill, Member and Volunteer Engagement Manager, ACCC, or call 301.984.9496, ext. 206.


2019 Clinical Research Award Recipient

headshot-Ethan-Basch-200x240Ethan Basch, MD, MSc
Director, Cancer Outcomes Research Program, UNC Lineberger Comprehensive Cancer Center; Professor, Hematology and Oncology; Associate Editor, Journal of the American Medical Association (JAMA).

Hear firsthand from Dr. Basch about the importance of collecting patient-reported outcomes (PROs) in routine practice to enhance clinical care. Learn about the significant findings his research has revealed, including potential survival advantages for patients.

begin-quoteI am a medical oncologist and health services researcher focused on developing methods to bring the patient perspective into cancer clinical research and routine care delivery. For over a decade, my group has developed and implemented patient-reported outcome (PRO) tools in these contexts, and worked closely with public and private agencies to effect policy changes based on our findings. My goal in these efforts is to foster inclusion of PROs in product development and FDA labels. Without such information, we cannot adequately understand people’s experiences during treatment, or make informed treatment decisions. It is my hope that bringing the patient voice into clinical research and care delivery processes will lead to safer drug development, improved quality of care, enhanced patient-clinician communication, and better patient experiences with disease and treatment.